BU-2313 A

produced by unidentified oligosporic actinomycete strain No. E864-61; broad antibiotic spectrum against G+ & G- anaerobic bacteria; BU-2313 for both BU-2313 A & BU-2313 B; see also BU-2313 B; RN given refers to (2R-(2alpha,3alpha,3aalpha,5alpha(1R*,2E,4E),6beta,7alpha,9abeta))-isomer; structure given in first source

Also Known As:

BU-2313 A, sodium salt; Bu 2313 A; 3a,7-epoxy-3aH-furo(3,2-b)oxocin-3-carboxylic acid, 5-(6-(2,5-dihydro-4-hydroxy-1-methyl-2-oxo-1H-pyrrol-3-yl)-1,3-dimethyl-6-oxo-2,4-hexadienyl)octahydro-2,6,9a-trimethyl-8-oxo-, methyl ester

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - BU-2313 A: 1

Related Diseases

1.	Infections 02/01/1980 - "Bu-2313 A and B each exhibited a broad antibiotic spectrum against Gram-positive and Gram-negative anaerobic bacteria, and showed in vivo activity against experimental infections produced by B. "

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)